Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter P Weber

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Annals of Surgical Oncology|October 31, 2023
Impact of Imaging-Guided Localization on Performance of Tailored Axillary Surgery in Patients with Clinically Node-Positive Breast Cancer: Prospective Cohort Study Within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)Walter P Weber, Martin Heidinger, Stefanie Hayoz, et al.
Oncogene|August 25, 2022
A high-throughput drug screen reveals means to differentiate triple-negative breast cancerMilica Vulin, Charly Jehanno, Atul Sethi, et al.
The Lancet. Oncology|January 2, 2021
Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolboxPeter Dubsky, Katja Pinker, Fatima Cardoso, et al.
The Cochrane Database of Systematic Reviews|February 13, 2025
Microsurgical versus complex physical decongestive therapy for chronic breast cancer-related lymphoedemaYvonne Haas, Olivia P Williams, Jaume Masia, et al.
BMJ Open|September 3, 2021
Prepectoral versus subpectoral implant-based breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy (OPBC-02/ PREPEC): a pragmatic, multicentre, randomised, superiority trialElisabeth A Kappos, Alexandra Schulz, Meredith M Regan, et al.
Cancer Treatment Reviews|May 1, 2023
Uncertainties and controversies in axillary management of patients with breast cancerWalter P Weber, Oreste Davide Gentilini, Monica Morrow, et al.
JAMA Surgery|July 19, 2023
Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast CancerWalter P Weber, Zoltan Matrai, Stefanie Hayoz, et al.
Breast (Edinburgh, Scotland)|September 23, 2021
Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)Walter P Weber, Zoltan Matrai, Stefanie Hayoz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2024
Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO StudyGiacomo Montagna, Alison Laws, Massimo Ferrucci, et al.
The Lancet. Oncology|December 25, 2025
Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort studyGiacomo Montagna, Michael Alvarado, Sara Myers, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Annals of Surgical Oncology|October 31, 2023
Impact of Imaging-Guided Localization on Performance of Tailored Axillary Surgery in Patients with Clinically Node-Positive Breast Cancer: Prospective Cohort Study Within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)Walter P Weber, Martin Heidinger, Stefanie Hayoz, et al.
Oncogene|August 25, 2022
A high-throughput drug screen reveals means to differentiate triple-negative breast cancerMilica Vulin, Charly Jehanno, Atul Sethi, et al.
The Lancet. Oncology|January 2, 2021
Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolboxPeter Dubsky, Katja Pinker, Fatima Cardoso, et al.
The Cochrane Database of Systematic Reviews|February 13, 2025
Microsurgical versus complex physical decongestive therapy for chronic breast cancer-related lymphoedemaYvonne Haas, Olivia P Williams, Jaume Masia, et al.
BMJ Open|September 3, 2021
Prepectoral versus subpectoral implant-based breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy (OPBC-02/ PREPEC): a pragmatic, multicentre, randomised, superiority trialElisabeth A Kappos, Alexandra Schulz, Meredith M Regan, et al.
Cancer Treatment Reviews|May 1, 2023
Uncertainties and controversies in axillary management of patients with breast cancerWalter P Weber, Oreste Davide Gentilini, Monica Morrow, et al.
JAMA Surgery|July 19, 2023
Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast CancerWalter P Weber, Zoltan Matrai, Stefanie Hayoz, et al.
Breast (Edinburgh, Scotland)|September 23, 2021
Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)Walter P Weber, Zoltan Matrai, Stefanie Hayoz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2024
Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO StudyGiacomo Montagna, Alison Laws, Massimo Ferrucci, et al.
The Lancet. Oncology|December 25, 2025
Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort studyGiacomo Montagna, Michael Alvarado, Sara Myers, et al.
Pageof 10